Analyzing Complex In Vitro Experiments: It’s Not as Hard as You Think

Analyzing in vitro experiments can be challenging and time consuming. Yet, crucial decisions depend on accurate data analysis and interpretation early in development. Unfortunately, most lab-based scientists lack access to state-of-the-art models for analyzing in vitro data. A new tool enables the analysis of data generated from complexin vitro studies. These studies include assays using … Continued

Certara Joins EU-ToxRisk – A Program Driving Mechanism-based Toxicity Testing and Risk Assessment

In a large (30 Million €) H2020-supported collaborative project, academia joins forces with small and medium-sized enterprises (SMEs), large industry, contract research organizations (CROs) and regulatory bodies to achieve a paradigm shift in toxicology towards a more efficient and animal-free chemical safety assessment. PRINCETON, NJ, Oct. 12, 2015 An international consortium of 39 partner organizations … Continued

Is Your Approach to Regulatory Writing the Elephant in the Room?

I’ve helped many clients navigate the world of regulatory writing to gain drug approvals. Our clients’ challenges remind me of the parable of the elephant and the blind men. If you’re not familiar with the story, it goes like this: A group of blind men hear that an elephant has arrived in their village. Being blind, … Continued

Certara Scientists Participate in 14 Presentations at 6th American Conference on Pharmacometrics

Diverse agenda underscores the widespread adoption of pharmacometrics throughout the drug development process PRINCETON, NJ – Oct. 02, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that its scientists are presenting or co-authoring 14 workshops, seminars and poster sessions at the sixth American Conference on Pharmacometrics (ACoP6). This annual International Society … Continued